Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Allergy Vaccine Companies

Allergy vaccines, also known as allergen immunotherapy, involve the administration of gradually increasing doses of specific allergens to desensitize the immune system and reduce allergic reactions. Companies involved in allergy vaccines operate in the pharmaceutical and biotechnology sectors, focusing on the development and manufacturing of immunotherapeutic products for allergy treatment.

Latest Allergy Vaccine Companies Update:

Merck Sharp & Dohme (MSD) Acquired Aimmune Therapeutics, gaining access to their peanut allergy vaccine, Palforzia, and strengthening their allergy treatment portfolio.

ALK-Abello Partnered with Regeneron on their investigational IL-4Rα antagonist, REGN1679, to explore its potential in treating severe allergic diseases.

Circassia Pharmaceuticals Received FDA approval for their grass pollen sublingual tablet allergy vaccine, Grazax®, expanding access to this treatment option.

Stallergenes Greer Launched their first sublingual tablet allergy vaccine for ragweed in the US, Oralair® (ambrosia artemisiifolia sublingual allergenic extract), further diversifying their product portfolio.

Immuno Laboratories Developed the Viaskin® Peanut, a next-generation epicutaneous allergy patch for peanut allergies, currently undergoing Phase 3 clinical trials.

LEO Pharma Announced positive Phase 2b results for their investigational peanut allergy patch, Omalizumab, demonstrating potential for future market entry.

List of Allergy Vaccine companies in the market

ALK (Denmark)

Stallergenes Greer (Switzerland)

Allergy Therapeutics (U.K.)

HAL Allergy B.V. (Netherlands)

HollisterStier Allergy (U.S.)

Zhejiang Wolwo Bio-pharmaceutical Co., Ltd (China)

LETIPharma (Spain)

Dermapharm Holding SE (Germany)

Allergy Vaccine Market Highlights:

Allergy Vaccine Market Size

Allergy Vaccine Market Trends

Allergy Vaccine Market Analysis

Allergy Vaccine Market Share

Allergy Vaccine Market Highlights:

Allergy Vaccine Market Trends

Allergy Vaccine Market Analysis

Allergy Vaccine Market Share

Allergy Vaccine Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.